A Quantitative ELISA Assay for the Fragile X Mental Retardation 1 Protein
AUTOR(ES)
Iwahashi, Christine
FONTE
American Society for Investigative Pathology
RESUMO
Non-coding (CGG-repeat) expansions in the fragile X mental retardation 1 (FMR1) gene result in a spectrum of disorders involving altered neurodevelopment (fragile X syndrome), neurodegeneration (late-onset fragile X-associated tremor/ataxia syndrome), or primary ovarian insufficiency. While reliable and quantitative assays for the number of CGG repeats and FMR1 mRNA levels are now available, there has been no scalable, quantitative assay for the FMR1 protein (FMRP) in non-transformed cells. Using a combination of avian and murine antibodies to FMRP, we developed a sensitive and highly specific sandwich enzyme-linked immunosorbent assay (ELISA) for FMRP in peripheral blood lymphocytes. This ELISA method is capable of quantifying FMRP levels throughout the biologically relevant range of protein concentrations and is specific for the intact FMRP protein. Moreover, the ELISA is well-suited for replicate protein determinations across serial dilutions in non-transformed cells and is readily scalable for large sample numbers. The FMRP ELISA is potentially a powerful tool in expanding our understanding of the relationship between FMRP levels and the various FMR1-associated clinical phenotypes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2710703Documentos Relacionados
- A nuclear role for the Fragile X mental retardation protein.
- Fragile X Mental Retardation Protein in the Driver's Seat
- X inactivation of the FMR1 fragile X mental retardation gene.
- The fragile X mental retardation protein has nucleic acid chaperone properties
- Characterization of dFMR1, a Drosophila melanogaster Homolog of the Fragile X Mental Retardation Protein